Vitaspring Biomedical annual operating margin
2018
2019
2020
2021
2022
Vitaspring Biomedical Operating Margin Growth & History (VSBC)
Vitaspring Biomedical's operating margin was 20.07% for fiscal 2022.
View full Vitaspring Biomedical company overviewVitaspring Biomedical annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-01-31 | 20.07% | −151.32 pp |
| 2021 | 2021-01-31 | 171.39% | +125.69 pp |
| 2020 | 2020-01-31 | 45.70% | +176.06 pp |
| 2019 | 2019-01-31 | −130.36% | −91.09 pp |
| 2018 | 2018-01-31 | −39.27% | — |
Vitaspring Biomedical quarterly operating margin
Q1.19
Q1.20
Q2.20
Q4.20
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2023 | 2022-04-30 | 23.03% | −10.58 pp |
| Q4 2022 | 2022-01-31 | 16.02% | −211.83 pp |
| Q3 2022 | 2021-10-31 | 68.73% | +819.18 pp |
| Q2 2022 | 2021-07-31 | 18.04% | +172.63 pp |
| Q1 2022 | 2021-04-30 | 33.61% | +151.56 pp |
| Q4 2021 | 2021-01-31 | 227.85% | +187.86 pp |
| Q4 2020 | 2020-01-31 | −750.46% | — |
| Q2 2020 | 2019-07-31 | −154.59% | — |
| Q1 2020 | 2019-04-30 | −117.95% | — |
| Q1 2019 | 2018-04-30 | 39.99% | — |
Vitaspring Biomedical operating margin trends
Across the available reported history, Vitaspring Biomedical's operating margin decreased from 171.39% to 20.07%, a change of −151.32 percentage points. The latest reported quarter, Q1 2023, shows 23.03%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vitaspring Biomedical filings at SEC.gov ↗